Maturity-Onset Diabetes of the Young, Type 2, also known as maturity-onset diabetes of the young type 2, is related to hyperinsulinemic hypoglycemia, familial, 1 and hyperinsulinemic hypoglycemia, familial, 2. An important gene associated with Maturity-Onset Diabetes of the Young, Type 2 is GCK (Glucokinase), and among its related pathways/superpathways are Nervous system development and Glucose / Energy Metabolism. The drugs Glucagon and Benzocaine have been mentioned in the context of this disorder. Affiliated tissues include liver and pancreas, and related phenotypes are maturity-onset diabetes of the young and Decreased viability